Atlas market file · Equity · United States
QTREX Quantum Ltd.QTEX
- Last close
- 1.06
- Change
- -1.85%
- 96-bar range
- 0.283 – 3.85
- As of
- 6 Aug 2026
QTREX Quantum Ltd. is a surgical & medical instruments & apparatus issuer listed as QTEX on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-10.17% over the window).
Source rail: Yahoo Finance chart API (QTEX). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for QTEX. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
QTEX public profile
Surgical & medical instruments & apparatus issuer. QTREX Quantum Ltd. is connected to current market context, cited company sources and its retained research file.
QTREX Quantum Ltd. trades as QTEX on NASDAQ. QTREX Quantum Ltd. (QTEX) has a latest verified close of 1.06, down 1.85%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files QTEX under USA Stocks for browsing.
What changed for QTREX Quantum Ltd. today
QTREX Quantum Ltd. spent $3.2 million in cash to acquire a proprietary Additively Manufactured Electronics (AME) platform from Nano Dimension in April 2026, a deal trumpeted as the foundation for its quantum connectivity products. Yet the company’s 20-F filing for the year ended 31 December 2025 shows total revenues of just $289,000, operating losses of $13.6 million, and net losses of $13.2 million, leaving the platform’s contribution to the top line invisible to the naked eye. The acquisition, described in the F-1 as ‘both the production foundation for our quantum products and AME Platform systems,’ now sits alongside $3.2 million in cash and equivalents on the balance sheet, a figure unchanged since the deal closed. (source: QTREX F-1 (2026-07-21), https://www.sec.gov/Archives/edgar/data/1837493/000118518526003070/qtrexf1072126.htm)
QTREX’s business is quantum, but its economics are distinctly analogue. The company’s 20-F for 2025 reports assets of $5.3 million, stockholders’ equity of $2.3 million, and negative operating cash flow of $9.9 million for the year, while research and development expense clocked in at $7.5 million. Inventory has risen by $291,000 to $735,000, a signal that either production is ramping or sales are not. The platform, meanwhile, is expected to serve as the production foundation for quantum products, but no revenues from quantum products are disclosed in the filing, leaving the link between the platform and the income statement as speculative as the timeline for quantum commercialisation. (source: QTREX 20-F (period ending 2025-12-31), https://www.sec.gov/Archives/edgar/data/1837493/000118518526003060/)
On the governance front, QTREX’s July 2026 filings reveal a board that is busy rearranging the share register. The company’s ownership update for 22 July 2026 shows a diluted weighted average share count of 29.6 million at year-end 2025, alongside an EPS of -$0.45. A 6-K filed on 21 July 2026 discloses an approved increase in the number of ordinary shares, no par value per share, a move typically associated with future capital raises or executive incentives. The optics are consistent with a company that is choosing dilution over profitability, at least for now. (source: QTREX 3 (2026-07-22), https://www.sec.gov/Archives/edgar/data/1837493/000118518526003089/xslF345X06/ownership.xml)
The company’s product pipeline remains anchored to the AME platform, but the filing trail does not show any near-term revenue visibility. The 20-F for 2025 reports $289,000 in total revenues, while inventory has climbed to $735,000, an increase of $291,000, suggesting either build-up for future sales or an admission that current products are not clearing the shelf. The platform’s role in quantum connectivity is asserted, not evidenced, in the filings, leaving investors to decide whether to bet on a technology story or a balance sheet that is haemorrhaging cash. (source: QTREX 20-F (period ending 2025-12-31), https://www.sec.gov/Archives/edgar/data/1837493/000118518526003060/)
For those tracking the company’s governance and capital moves, the July 2026 filings offer a masterclass in optics versus substance. The board’s decision to increase the share count, paired with the absence of any revenue from quantum products in the 20-F, frames the current strategy as a bet on future technology rather than current cash generation. Whether that bet pays off remains an open question, but the filings make one thing clear: the company’s cash pile is not growing, and the losses are not shrinking. (source: QTREX 6-K (2026-07-21), https://www.sec.gov/Archives/edgar/data/1837493/000118518526003063/qtrex6k072026.htm)
The company’s S-8 filing on 21 July 2026, alongside multiple 6-K and ownership updates in the same week, suggests a flurry of administrative activity rather than a surge in commercial momentum. The absence of any disclosure of revenues from quantum products, the flat cash balance since the Nano Dimension acquisition, and the rise in inventory all point to a company that is spending to build capacity it has not yet monetised. The AME platform may yet prove transformative, but the filings do not yet show it transforming anything into revenue. (source: QTREX S-8 (2026-07-21), https://www.sec.gov/Archives/edgar/data/1837493/000118518526003062/qtrexs8072026.htm)
If the goal is to keep the lights on while waiting for quantum to pay rent, the evidence suggests the rent is still comfortably beyond the due date. The board’s share-count increase, the flat cash balance, and the absence of quantum revenues in the 20-F collectively frame a company that is choosing to fund its ambitions through dilution rather than profitability-for now. (source: QTREX 20-F (period ending 2025-12-31), https://www.sec.gov/Archives/edgar/data/1837493/000118518526003060/)
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
QTEX technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on QTEX
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep QTEX research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
QTEX FAQ
What is QTREX Quantum Ltd. (QTEX)?QTREX Quantum Ltd. (QTEX) has a latest verified close of 1.06, down 1.85%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed...
QTREX Quantum Ltd. (QTEX) has a latest verified close of 1.06, down 1.85%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for QTEX?QTREX Quantum Ltd. (QTEX) has a latest verified close of 1.06, down 1.85%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks...
QTREX Quantum Ltd. (QTEX) has a latest verified close of 1.06, down 1.85%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files QTEX under USA Stocks for browsing.
How often is the QTEX page updated?The QTEX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The QTEX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for QTEX?The QTEX file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:QTEX. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The QTEX file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:QTEX. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on QTEX?Yes. The workstation can open QTEX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open QTEX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this QTEX page investment advice?No. The QTEX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The QTEX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
QTEX
Equity · evidence first